Oct. 21, 2002 — Low-flow cerebroventricular shunting may be worth investigating further in Alzheimer's disease, according to the authors of a pilot study reported in the Oct. 22 issue of Neurology.

Implementing improved pathologic nodal (pN) staging during non-small cell lung cancer (NSCLC) resection: A population-based study. This is an ASCO Meeting Abstract from the 2018 ASCO Annual Meeting I.

The first generation of CSF biomarkers for Alzheimer disease comprises those that measure the component proteins of the disease’s signature pathologic lesions. They have been explored for almost 15 ...

Despite extensive use of biomarkers in research studies, most Alzheimer’s disease diagnoses in the United States are determined by clinical examination. That may be about to change. The Food and Drug ...

Cerebrospinal fluid (CSF) is a clear bodily fluid that cushions and protects your brain and spinal cord. A CSF protein test involves taking a fluid sample from your spinal column using a needle. This ...

The U.S. Food and Drug Administration today allowed marketing of the first cerebrospinal fluid (CSF) nucleic acid-based test for simultaneous detection of multiple pathogens that can cause central ...

Cerebrospinal fluid (CSF) is a clear and watery liquid that flows in and around the brain and spinal cord. Its functions include protecting parts of the nervous system, delivering nutrients and ...